These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Establishment of a cisplatin-resistant human ovarian cancer cell line. Kikuchi Y, Miyauchi M, Kizawa I, Oomori K, Kato K. J Natl Cancer Inst; 1986 Dec; 77(6):1181-5. PubMed ID: 3467111 [Abstract] [Full Text] [Related]
4. [Reduced cisplatin-uptake by cisplatin-resistant human ovarian cancer cells]. Kikuchi Y, Iwano I, Miyauchi M. Gan To Kagaku Ryoho; 1988 Oct; 15(10):2895-8. PubMed ID: 3178239 [Abstract] [Full Text] [Related]
5. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro. Yanagie H, Hisa T, Ogata A, Miyazaki A, Nonaka Y, Nishihira T, Osada I, Sairennji T, Sugiyama H, Furuya Y, Kidani Y, Takamoto S, Takahashi H, Eriguchi M. Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892 [Abstract] [Full Text] [Related]
6. The mechanism of acquired resistance to cisplatin by a human ovarian cancer cell line. Kikuchi Y, Iwano I, Miyauchi M, Kita T, Oomori K, Kizawa I, Sugita M, Tenjin Y. Jpn J Cancer Res; 1988 May; 79(5):632-5. PubMed ID: 3136116 [Abstract] [Full Text] [Related]
8. [Drug resistant mechanisms of platinum derivatives in a human cisplatin resistant ovarian cancer cell line]. Nishiya I, Yoshizumi N, Fujiwara J, Kagabu T. Gan To Kagaku Ryoho; 1988 Oct; 15(10):2871-81. PubMed ID: 3178236 [Abstract] [Full Text] [Related]
11. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray. Sakamoto M, Kondo A, Kawasaki K, Goto T, Sakamoto H, Miyake K, Koyamatsu Y, Akiya T, Iwabuchi H, Muroya T, Ochiai K, Tanaka T, Kikuchi Y, Tenjin Y. Hum Cell; 2001 Dec; 14(4):305-15. PubMed ID: 11925933 [Abstract] [Full Text] [Related]
12. [Therapeutic values of prostaglandin D2 in nude mice bearing human ovarian carcinoma]. Kikuchi Y, Miyauchi M, Nagata I. Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):121-8. PubMed ID: 2313142 [Abstract] [Full Text] [Related]
13. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation. Kikuchi Y, Kizawa I, Oomori K, Miyauchi M, Kita T, Sugita M, Tenjin Y, Kato K. Cancer Res; 1987 Jan 15; 47(2):592-6. PubMed ID: 3791243 [Abstract] [Full Text] [Related]
14. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line. Kelland LR, Mistry P, Abel G, Freidlos F, Loh SY, Roberts JJ, Harrap KR. Cancer Res; 1992 Apr 01; 52(7):1710-6. PubMed ID: 1312897 [Abstract] [Full Text] [Related]
15. [Establishment of a cisplatin-resistant human ovarian cancer cell line]. Sasa H, Hisano A, Ishii K, Hirata J, Kikuchi Y, Nagata I, Senoo A, Aida S, Tamai S, Sugita M. Hum Cell; 1993 Jun 01; 6(2):106-13. PubMed ID: 8217948 [Abstract] [Full Text] [Related]
16. [In vitro and in vivo effects of ginsenoside Rh2 on the proliferation of serous cystadenocarcinoma of the human ovary]. Tode T, Kikuchi Y, Sasa H, Hirata J, Kita T, Imaizumi E, Nagata I. Nihon Sanka Fujinka Gakkai Zasshi; 1992 May 01; 44(5):589-94. PubMed ID: 1619319 [Abstract] [Full Text] [Related]
17. Effects of calmodulin antagonists on human ovarian cancer cell proliferation in vitro. Kikuchi Y, Iwano I, Kato K. Biochem Biophys Res Commun; 1984 Aug 30; 123(1):385-92. PubMed ID: 6541042 [Abstract] [Full Text] [Related]
18. [Cancer chemo-endocrine therapy and its cell biological basis]. Nishiya I. Hum Cell; 1998 Sep 30; 11(3):109-14. PubMed ID: 10086273 [Abstract] [Full Text] [Related]